Magnitude Biosciences

Magnitude Biosciences has secured £1.3 million in funding to expand its VivoScan screening platform and accelerate drug discovery operations.

Summary of transaction details:

• Value: £1.3 million
• Sector: Healthcare & Biotech
• Advisor: Not disclosed
• Key Entities: Magnitude Biosciences, Northstar Ventures
• Location: Sedgefield, County Durham

Note: The investment will enable the biosciences firm to scale its proprietary technology targeting ageing and neurodegenerative diseases, supporting international expansion and job creation.